New Clue: Prediction from Cell-Free DNA
The main challenge for a positive long-term outcome in lung transplantation is the lack of early detection for chronic lung allograft dysfunction (CLAD). With advancements in technology, an increasing number of studies demonstrate that cell-free DNA (cfDNA) in body fluids could be used as a marker f...
Main Author: | Yan Y. Sanders |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/7/2307 |
Similar Items
-
Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival
by: Joshua Y.C. Yang, et al.
Published: (2019-02-01) -
The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status
by: Charat Thongprayoon, et al.
Published: (2020-05-01) -
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
by: Morten Lapin, et al.
Published: (2018-11-01) -
Analysis of microbial sequences in plasma cell-free DNA for early-onset breast cancer patients and healthy females
by: Yu-Feng Huang, et al.
Published: (2018-02-01) -
Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
by: Stefan Grabuschnig, et al.
Published: (2020-10-01)